Interferon beta babies

Neurology

Volumn 65, Issue 6, 2005, Pages 788-789

  Waubant, Emmanuelle ^a   Sadovnick, A Dessa ^b  

^a UCSF Multiple Sclerosis Center   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER; PLACEBO;

BIRTH WEIGHT; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; FAMILY HISTORY; FETUS DEATH; HUMAN; LACTATION; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY COMPLICATION; PREGNANCY RATE; PREMATURITY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SIDE EFFECT; TERATOGENICITY;

EID: 25444437713     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000182147.73071.2c     Document Type: Editorial

References (5)

1. Sandberg-Wollheim M, Frank D, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005;65:802-806.
2. Boskovic R, Wade R, Wolpin J, Bauer G, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005;65:807-811.
3. Coyle PK, Johnson K, Pardo L, Stark Y. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). Neurology 2003;60(suppl 1):A60.
4. Armenti VT, Radomski JS, Moritz MJ. et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. In: Cecka, Terasaki, eds. Clinical transplants. Los Angeles: UCLA Immunogen Center, 2004:103-119.
5. Walther EU, Hohlfeld R. Multiple sclerosis: side effects of interferon therapy and their management. Neurology 1999;53:1622-1627.